Related references
Note: Only part of the references are listed.Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
Amin Gasmi et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)
Of chloroquine and COVID-19
Franck Touret et al.
ANTIVIRAL RESEARCH (2020)
Advance of promising targets and agents against COVID-19 in China
Yongtao Duan et al.
DRUG DISCOVERY TODAY (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Matthieu Million et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Pyrimethamine Elicits Antitumor Effects on Prostate Cancer by Inhibiting the p38-NF-κB Pathway
Xumin Zhou et al.
FRONTIERS IN PHARMACOLOGY (2020)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Qingxian Cai et al.
ENGINEERING (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A comparative study on the time to achieve negative nucleic acid testing and hospital stays between danoprevir and lopinavir/ritonavir in the treatment of patients with COVID-19
Zhicheng Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
Mark P. Lythgoe et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Liying Dong et al.
DRUG DISCOVERIES AND THERAPEUTICS (2020)
Advances in respiratory virus therapeutics - A meeting report from the 6th for isirv Antiviral Group conference
John H. Beigel et al.
ANTIVIRAL RESEARCH (2019)
Respiratory syncytial virus infection in adults
Hannah H. Nam et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Pyrimethamine inhibits rabies virus replication in vitro
Sophie Rogee et al.
ANTIVIRAL RESEARCH (2019)
Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans
Kashyap Patel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Biochemical characterization of the respiratory syncytial virus N0-P complex in solution
Camille Esneau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Antimalarial Drug Pyrimethamine Plays a Dual Role in Antitumor Proliferation and Metastasis through Targeting DHFR and TP
Huijuan Liu et al.
MOLECULAR CANCER THERAPEUTICS (2019)
An evaluation of Chloroquine as a broad-acting antiviral against Hand, Foot and Mouth Disease
Yong Wah Tan et al.
ANTIVIRAL RESEARCH (2018)
Antiviral Activity of Oral JNJ-53718678 in Healthy Adult Volunteers Challenged With Respiratory Syncytial Virus: A Placebo-Controlled Study
Marita Stevens et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs
Alejandro Larios Mora et al.
MABS (2018)
Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants
Joseph B. Domachowske et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2018)
RSV hijacks cellular protein phosphatase 1 to regulate M2-1 phosphorylation and viral transcription
Charles-Adrien Richard et al.
PLOS PATHOGENS (2018)
Review of Drug Repositioning Approaches and Resources
Hanqing Xue et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin
Young-In Kim et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2017)
Nicotinamide inhibits the growth of P. falciparum and enhances the antimalarial effect of artemisinin, chloroquine and pyrimethamine
Sergey O. Tcherniuk et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2017)
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
Chunfeng Li et al.
EBIOMEDICINE (2017)
Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models
Rodrigo Delvecchio et al.
VIRUSES-BASEL (2016)
Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules
O. Ferraris et al.
ANTIVIRAL RESEARCH (2015)
Pgp efflux pump decreases the cytostatic effect of CENP-E inhibitor GSK923295
Sergey O. Tcherniuk et al.
CANCER LETTERS (2015)
Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
Lindsay Broadbent et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2015)
Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model
Stuart D. Dowall et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics
Eric A. F. Simoes et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
John P. DeVincenzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mechanism of Action for Respiratory Syncytial Virus Inhibitor RSV604
SreeRupa Challa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Management of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies
Roy F. Chemaly et al.
CLINICAL INFECTIOUS DISEASES (2014)
Chloroquine interferes with dengue-2 virus replication in U937 cells
Kleber Juvenal Silva Farias et al.
MICROBIOLOGY AND IMMUNOLOGY (2014)
Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study
John P. DeVincenzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Visualizing the replication of respiratory syncytial virus in cells and in living mice
Marie-Anne Rameix-Welti et al.
NATURE COMMUNICATIONS (2014)
Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
Yiwu Yan et al.
CELL RESEARCH (2013)
High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections
N. Lee et al.
CLINICAL INFECTIOUS DISEASES (2013)
Complete Genome Sequence of Human Respiratory Syncytial Virus Genotype A with a 72-Nucleotide Duplication in the Attachment Protein G Gene
Wan-Ji Lee et al.
JOURNAL OF VIROLOGY (2012)
Management of RSV infections in adult recipients of hematopoietic stem cell transplantation
Jharna N. Shah et al.
BLOOD (2011)
Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways
Ayumi Takakura et al.
HUMAN MOLECULAR GENETICS (2011)
Chikungunya Disease and Chloroquine Treatment
Ilenia Delogu et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
Peter L. Collins et al.
VIRUS RESEARCH (2011)
Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy
Tomokazu Mizui et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection
Alexander N. Freiberg et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication
Raphael M. Oguariri et al.
VIRUS RESEARCH (2010)
Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice
Els Keyaerts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Simulating Henipavirus Multicycle Replication in a Screening Assay Leads to Identification of a Promising Candidate for Therapy
Matteo Porotto et al.
JOURNAL OF VIROLOGY (2009)
In vitro inhibition of human influenza A virus replication by chloroquine
Eng Eong Ooi et al.
VIROLOGY JOURNAL (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Respiratory syncytial virus infection in elderly adults
AR Falsey et al.
DRUGS & AGING (2005)
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap
A Kentsis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein ollgomerization domain
N Castagné et al.
JOURNAL OF GENERAL VIROLOGY (2004)
The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase
CE Cameron et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2001)
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin
S Ghosh et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
